Safety of osimertinib in Chinese patients with non-small cell lung cancer: a multi-center, prospective, observational study

Hua Zhong, Shunjun Jiang, Wenxiu Yao, Xia Song, Dongqing Lv, Dan Zhu, Yubiao Guo, Cuimin Ding, Yingjie Xue, Xiuli Bai, Liguo Xiao, Peifeng Chen, Yan Wang, Panwen Tian, Gen Lin, Wen Li, Jun Chen, Yanping Hu, Bing Xia, Ziping Wang, Hao Long, Weirong Yao, Haibo Zhang, Qiong Zhao, Yuli Wang, Liqin Lu, Weiming Duan, Ligang Xing, Fujun Yang, Yuan Chen, Yang Wei, Baohui Han, Jianxing He

Open source

DOI: 10.1080/14796694.2025.2579208
Published: 2025-10-30
Container: Future Oncology
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/14796694.2025.2579208,
  title = {Safety of osimertinib in Chinese patients with non-small cell lung cancer: a multi-center, prospective, observational study},
  author = {Hua Zhong and Shunjun Jiang and Wenxiu Yao and Xia Song and Dongqing Lv and Dan Zhu and Yubiao Guo and Cuimin Ding and Yingjie Xue and Xiuli Bai and Liguo Xiao and Peifeng Chen and Yan Wang and Panwen Tian and Gen Lin and Wen Li and Jun Chen and Yanping Hu and Bing Xia and Ziping Wang and Hao Long and Weirong Yao and Haibo Zhang and Qiong Zhao and Yuli Wang and Liqin Lu and Weiming Duan and Ligang Xing and Fujun Yang and Yuan Chen and Yang Wei and Baohui Han and Jianxing He},
  year = {2025},
  journal = {Future Oncology},
  doi = {10.1080/14796694.2025.2579208},
  url = {https://doi.org/10.1080/14796694.2025.2579208}
}

RIS

TY  - JOUR
TI  - Safety of osimertinib in Chinese patients with non-small cell lung cancer: a multi-center, prospective, observational study
AU  - Hua Zhong
AU  - Shunjun Jiang
AU  - Wenxiu Yao
AU  - Xia Song
AU  - Dongqing Lv
AU  - Dan Zhu
AU  - Yubiao Guo
AU  - Cuimin Ding
AU  - Yingjie Xue
AU  - Xiuli Bai
AU  - Liguo Xiao
AU  - Peifeng Chen
AU  - Yan Wang
AU  - Panwen Tian
AU  - Gen Lin
AU  - Wen Li
AU  - Jun Chen
AU  - Yanping Hu
AU  - Bing Xia
AU  - Ziping Wang
AU  - Hao Long
AU  - Weirong Yao
AU  - Haibo Zhang
AU  - Qiong Zhao
AU  - Yuli Wang
AU  - Liqin Lu
AU  - Weiming Duan
AU  - Ligang Xing
AU  - Fujun Yang
AU  - Yuan Chen
AU  - Yang Wei
AU  - Baohui Han
AU  - Jianxing He
PY  - 2025
JO  - Future Oncology
DO  - 10.1080/14796694.2025.2579208
UR  - https://doi.org/10.1080/14796694.2025.2579208
ER  -

APA

Zhong, H., Jiang, S., Yao, W., Song, X., Lv, D., Zhu, D., Guo, Y., Ding, C., Xue, Y., Bai, X., Xiao, L., Chen, P., Wang, Y., Tian, P., Lin, G., Li, W., Chen, J., Hu, Y., Xia, B., Wang, Z., Long, H., Yao, W., Zhang, H., Zhao, Q., Wang, Y., Lu, L., Duan, W., Xing, L., Yang, F., Chen, Y., Wei, Y., Han, B., & He, J. (2025). Safety of osimertinib in Chinese patients with non-small cell lung cancer: a multi-center, prospective, observational study. Future Oncology. https://doi.org/10.1080/14796694.2025.2579208

Source records

crossref · retrieved 2026-09-26T08:55:43.794Z